Fernández Díaz et al., 2019 - Google Patents
Role of insulin-degrading enzyme (ide) in pancreatic beta-cell function: relevance in health and diabetes mellitusFernández Díaz et al., 2019
View PDF- Document ID
- 11382375383498354376
- Author
- Fernández Díaz C
- et al.
- Publication year
External Links
Snippet
Insulin-degrading enzyme (IDE) is a zinc metalloprotease proposed as the main responsible for degrading insulin, in addition to degrading other peptides such as glucagon, amylin, and amyloid peptide. The association of genetic polymorphisms within the Ide locus and …
- 102100009274 IDE 0 title abstract description 653
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shao et al. | De novo adipocyte differentiation from Pdgfrβ+ preadipocytes protects against pathologic visceral adipose expansion in obesity | |
| Zhang et al. | Gq activity-and β-arrestin-1 scaffolding-mediated ADGRG2/CFTR coupling are required for male fertility | |
| JP6195891B2 (en) | Method for producing enteroendocrine cells that produce and secrete insulin | |
| Zhang et al. | The pathogenic mechanism of diabetes varies with the degree of overexpression and oligomerization of human amylin in the pancreatic islet β cells | |
| Leslie et al. | c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis | |
| US11014896B2 (en) | TRPA1 and TRPV4 inhibitors and methods of using the same for organ-specific inflammation and itch | |
| Choi et al. | Vhl is required for normal pancreatic β cell function and the maintenance of β cell mass with age in mice | |
| WO2014153385A2 (en) | Methods of treating metabolic disorders | |
| JPWO2006134692A1 (en) | Vascular structure stabilizer and angiogenic agent targeting RAMP2 | |
| JPWO2006134692A6 (en) | Vascular structure stabilizer and angiogenic agent targeting RAMP2 | |
| Bhatia et al. | Acinar cell-specific knockout of the PTHrP gene decreases the proinflammatory and profibrotic responses in pancreatitis | |
| US20100143330A1 (en) | Methods of treating disorders associated with fat storage | |
| Patel et al. | Melanocortin 3 receptor regulates hepatic autophagy and systemic adiposity | |
| Shinde et al. | Neuronatin is a stress-responsive protein of rod photoreceptors | |
| JP6825910B2 (en) | Flattop (Fltp) is a novel biomarker for β-cell maturation | |
| Fernández Díaz | Role of insulin-degrading enzyme (ide) in pancreatic beta-cell function: relevance in health and diabetes mellitus | |
| Díaz et al. | Role of insulin-degrading enzyme (ide) in pancreatic beta-cell function: relevance in health and diabetes mellitus | |
| D'souza | The effects of leptin knockout and insulin suppression on glucose metabolism in rodents | |
| Yingying | Environmental input to the pancreatic β-cells-the role of mechanosensitive and other ion channels | |
| Neumann | The metabolic effects of leptin therapy and glucagon suppression therapy in mouse models of diabetes | |
| Shen | Investigating the Molecular Mechanisms Underlying Lipo-toxicity in Diabetic Cardiomyopathy: KLB and FGFR1 Interaction and Signaling | |
| Cai | Allelic Insufficiency of Zinc Transporter 8 (Znt8) In Mice and Its Effect on T2D Prevention | |
| Sabatini | The Role of NPAS4 in Glucose Homeostasis | |
| Vergari | Regulation of somatostatin secretion from pancreatic δ-cells | |
| Shao et al. | Nat Commun-De novo adipocyte differentiation from Pdgfrβ+ preadipocytes protects against pathologic visceral adipose expansion in obesity. pdf |